Evidence map›Paper›PMID 42609305›Full record

ArticleFrontiers in cellular and infection microbiology2026

Epidemiologic and clinical characteristics of

Dewu Bi, Chaoyou Chen, Hailing Yu, Qiuying Ma, Xiaocheng Luo, Huawei He, Xike Tang, Chaojuan Liang, Lemin Wen, Shaoyong Xi and 11 more

Abstract read
In one paragraph

Article in Frontiers in cellular and infection microbiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

21 authors.

Dewu Bi *Department of Clinical Laboratory, The Fourth People's Hospital of Nanning, Nanning, Guangxi, China.
Chaoyou Chen *Human Immunodeficiency Virus/Acquired Immune Deficiency Syndrome (HIV/AIDS) Clinical Treatment Center of Guangxi, Nanning, Guangxi, China.
Hailing Yu *Department of Clinical Laboratory, The Fourth People's Hospital of Nanning, Nanning, Guangxi, China.
Qiuying MaDepartment of Clinical Laboratory, The Fourth People's Hospital of Nanning, Nanning, Guangxi, China.
Xiaocheng LuoKey Laboratory of Infectious Diseases, The Nanning Municipal Health Commission, Nanning, Guangxi, China.
Huawei HeHuman Immunodeficiency Virus/Acquired Immune Deficiency Syndrome (HIV/AIDS) Clinical Treatment Center of Guangxi, Nanning, Guangxi, China.
Xike TangHuman Immunodeficiency Virus/Acquired Immune Deficiency Syndrome (HIV/AIDS) Clinical Treatment Center of Guangxi, Nanning, Guangxi, China.
Chaojuan LiangDepartment of Clinical Laboratory, The Fourth People's Hospital of Nanning, Nanning, Guangxi, China.
Lemin WenHuman Immunodeficiency Virus/Acquired Immune Deficiency Syndrome (HIV/AIDS) Clinical Treatment Center of Guangxi, Nanning, Guangxi, China.
Shaoyong XiDepartment of Clinical Laboratory, The Fourth People's Hospital of Nanning, Nanning, Guangxi, China.
Zeduan LiuDepartment of Clinical Laboratory, The Fourth People's Hospital of Nanning, Nanning, Guangxi, China.
Wanhong HuangDepartment of Clinical Laboratory, The Fourth People's Hospital of Nanning, Nanning, Guangxi, China.
Qian LongDepartment of Clinical Laboratory, The Fourth People's Hospital of Nanning, Nanning, Guangxi, China.
Hanzhen SuDepartment of Clinical Laboratory, The Fourth People's Hospital of Nanning, Nanning, Guangxi, China.
Xiaolu LuoKey Laboratory of Infectious Diseases, The Nanning Municipal Health Commission, Nanning, Guangxi, China.
Wei WeiDepartment of Clinical Laboratory, The Fourth People's Hospital of Nanning, Nanning, Guangxi, China.
Zizhi PangDepartment of Clinical Laboratory, The Fourth People's Hospital of Nanning, Nanning, Guangxi, China.
Ningrong HuangDepartment of Clinical Laboratory, The Fourth People's Hospital of Nanning, Nanning, Guangxi, China.
Zongyou WeiDepartment of Clinical Laboratory, The Fourth People's Hospital of Nanning, Nanning, Guangxi, China.
Honghua ShaoHuman Immunodeficiency Virus/Acquired Immune Deficiency Syndrome (HIV/AIDS) Clinical Treatment Center of Guangxi, Nanning, Guangxi, China.
Zhouhua XieHuman Immunodeficiency Virus/Acquired Immune Deficiency Syndrome (HIV/AIDS) Clinical Treatment Center of Guangxi, Nanning, Guangxi, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Tuberculosis, caused by Methods: This study retrospectively analyzed patients with suspected tuberculosis who were hospitalized for pneumonia between January 2018 and December 2023 based on an electronic medical records database. Results: 37,204 patients were included in this study, comprising 34,429 patients with tuberculosis and 2,775 patients with non-tuberculosis lung diseases. Male, human immunodeficiency virus, hepatitis B virus, cytomegalovirus, diabetes, and stroke are risk factors associated with an increased infection of tuberculosis. Poor adherence and human immunodeficiency virus infection are linked to the development of antibiotic resistance in Conclusion: This study identified risk factors accounting for the infection and drug resistance of tuberculosis in Guangxi, China, from other illness. The diversity of coinfections among patients with tuberculosis highlights the importance of raising awareness about the multiplicity of infections.

Indexed as

Mycobacterium tuberculosisTuberculosisAdolescentAdultAgedAntitubercular AgentsChinaCoinfectionDrug Resistance, BacterialFemaleHIV InfectionsHumansMaleMiddle AgedRetrospective StudiesRisk FactorsAntitubercular Agentsclinical characteristicsdrug resistanceepidemiologyrisk factorstuberculosis

Identifiers

PMID42609305
PMCPMC13478008

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.